Dual Transgenic Mice for Endothelial Cell Research (Ve-Cadherin Cre-Recombinase - Rosa26r-YFP)
- 技术优势
- Endothelial-specific gene recombination ensures that only endothelial cells are labeled with YFP
- 技术应用
- Use as a model system to investigate endothelial gene expression in the context of either physiological or pathological conditions
- 详细技术说明
- UCLA researchers have developed a dual transgenic animal that enables genetic tracing of endothelial cells and their derivatives. Specifically, endothelial cells are labeled with YFP, and an endothelial-specific promoter drives Cre-recombinase (VE-Cadherin).
- *Abstract
-
UCLA researchers have developed a dual transgenic animal that enables genetic tracing of endothelial cells and their derivatives.
- *Applications
-
Use as a model system to investigate endothelial gene expression in the context of either physiological or pathological conditions
- *Principal Investigation
-
Name: Luisa Iruela-Arispe
Department:
- 其他
-
State Of Development
The mouse model has been developed, validated, and communicated to the scientific community. Background
Disturbances in endothelial gene expression contribute to vascular morphogenesis and tumor growth. Over the past century, the mouse has emerged as the premier mammalian model system for genetic research. Its genetic and physiological similarities to humans, as well as the ease with which its genome can be manipulated, make it especially attractive as models for human disease. Thus, mouse models that enable genetic tracing of endothelial cells would be of great use to vascular biologists. Additional Technologies by these Inventors
- VE-cadherin-CreERT2 Transgenic Mouse
- Floxed Mouse for Progesterone Receptor (PRCE)
- VE-Cadherin-Cre-recombinase Transgenic Mouse
- Transgenic Mice for Endothelial Cell Research (Ve-Cadherin Cre-Recombinase - Rosa26r-LacZ)
- Diagnosis and Treatment of Arteriovenous Malformations
Tech ID/UC Case
22805/2011-725-0
Related Cases
2011-725-0
- 国家/地区
- 美国

欲了解更多信息,请点击 这里